RTI Surgical® Wins 2019 MedTech Breakthrough Award for TETRAfuse® 3D Technology
June 05 2019 - 8:05AM
RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical
implant company, today announced MedTech Breakthrough has
selected TETRAfuse® 3D Technology as the “Best New Technology
Solution - Orthopedics” in their 2019 Awards Program. MedTech
Breakthrough is an independent organization recognizing the top
companies and solutions in the global health and medical technology
market. This year’s program attracted more than 3,500 nominations
from over 15 different countries.
TETRAfuse 3D Technology is featured
in RTI’s growing family of Fortilink® Interbody Fusion
(IBF) Devices, including the Fortilink-C, -TS and -L IBF Systems.
With its bone-like mechanical properties, radiolucency and
antibacterial characteristics, TETRAfuse 3D Technology has a unique
design to participate in fusion and help drive optimal outcomes for
patients undergoing spinal fusion procedures.
“We are pleased our TETRAfuse 3D Technology
continues to receive recognition as one of the best new
technologies in spine care,” said Camille Farhat, President and
CEO, RTI Surgical. “This recognition, combined with our ongoing
clinical research on the effectiveness of the Fortilink IBF Systems
with TETRAfuse 3D Technology in patients with degenerative disc
disease, reinforces surgeon confidence in this important treatment
option for spine patients.”
TETRAfuse 3D Technology also won a 2018 Spine
Technology Award from Orthopedics This Week. It is
manufactured under an exclusive license agreement with Oxford
Performance Materials, Inc. (OPM), which grants RTI Surgical use of
OPM’s technology for spinal applications in the U.S. For more
information, please visit www.tetrafuse3D.com.
“RTI Surgical has a proven track record of
developing innovative, safe and effective spine solutions that are
supported by clinical research, and the TETRAfuse 3D Technology
solution is a shining example of a technology ‘breakthrough’ that
embodies the innovative spirit of our awards program,” said James
Johnson, Managing Director, MedTech Breakthrough. “Congratulations
to the RTI Surgical team on its success and well-deserved 2019
MedTech Breakthrough Award!”
The mission of the MedTech Breakthrough Awards
is to honor excellence and recognize the innovation, hard work and
success in a range of health and medical technology categories.
About RTI Surgical Holdings,
Inc.RTI Surgical is a leading global surgical implant
company providing surgeons with safe biologic, metal and synthetic
implants. Committed to delivering a higher standard, RTI’s implants
are used in spine, sports medicine, general surgery, orthopedic and
trauma procedures and are distributed in nearly 50 countries. RTI
has four manufacturing facilities throughout the U.S. and Europe.
RTI is accredited in the U.S. by the American Association of Tissue
Banks and is a member of AdvaMed. For more information,
visit www.rtix.com. Connect with us
on LinkedIn and Twitter.
About MedTech Breakthrough Part
of Tech Breakthrough, a leading market intelligence and recognition
platform for global technology innovation and leadership, the
MedTech Breakthrough Awards program is an independent program
devoted to honoring excellence in medical and health related
technology companies, products, services and people. The MedTech
Breakthrough Awards provide a platform for public recognition
around the achievements of breakthrough health and medical
companies and products in categories that include Patient
Engagement, mHealth, Health & Fitness, Clinical Administration,
Healthcare IoT, Medical Data, Healthcare Cybersecurity and more.
For more information visit MedTechBreakthrough.com.
Steven Cohen Media Contact
scohen@rtix.com +1 847 648 0861
Molly Poarch Investor Contact
mpoarch@rtix.com +1 224 287 2661
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/11955818-aa5c-467d-99f9-aa22a3680a68
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Aug 2024 to Sep 2024
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Sep 2023 to Sep 2024